There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for BioLineRx Ltd. (BLRX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.02, or 1.48%, to $1.37. The BioLineRx Ltd. has recorded 1,744 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted BioLineRx Regains Compliance with Nasdaq Minimum Bid Price Requirement.
<25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $1.35 and fluctuated between $1.3693 as its day high and $1.2600 as its day low. The current market capitalization of BioLineRx Ltd. is $85.09M. A total of 1.01 million shares were traded on the day, compared to an average of 460.72K shares.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for BLRX in the last 3 months, the mean price target is $9.67 with high estimates of $19.00 and low estimates of $4.00. In terms of 52-week highs and lows, BLRX has a high of $1.98 and a low of $0.55.
As of this writing, BLRX has an earnings estimate of -$0.15 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.14 per share and a lower estimate of -$0.16. The company reported an EPS of -$0.15 in the last quarter, which was -66.70% lower than expectations of -$0.09.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. BLRX’s latest balance sheet shows that the firm has $57.13M in Cash & Short Term Investments as of fiscal 2021. There were $4.65M in debt and $9.72M in liabilities at the time. Its Book Value Per Share was $1.12, while its Total Shareholder’s Equity was $68.09M.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BLRX is Buy with a score of 5.00.